Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia — Stella

Home/Hypoxic Ischemic Encephalopathy/

View on ClinicalTrials.gov

Recruiting

Back to Hypoxic Ischemic Encephalopathy trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(2 sites)

United States

University of Florida, Gainesville, Florida

Florida Hospital for Children, Orlando, Florida

Key details

Phase

Very early testing

Sponsor

University of Florida

Collaborators

Thrasher Research Fund

Enrollment target

~70 participants

Started

November 2016

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.